- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr David Blumenthal Looks Back as The Commonwealth Fund Celebrates 100 Years
As The Commonwealth Fund celebrates 100 years, David Blumenthal, MD, MPP, looks back at the work it has done.
As The Commonwealth Fund celebrates 100 years, David Blumenthal, MD, MPP, looks back at the work it has done.
Transcript
This year, the Commonwealth Fund is celebrating their 100th year, and you have launched a website in commemoration. How has the organization worked to improve healthcare over the years?
Well, we have over the last 100 years we’ve been committed to improving the health of the American people as well as working on international issues and to improving the care, especially of vulnerable populations. Some of the things we’ve done over the years, we were among the original supporters of the Pap Smear. We’ve also helped fund rural hospitals in the south and that led to the program called the Hillburton Act which funded hospitals throughout the United States in the 40s and 50s. We were the first supporter of hospice in the United States, we funded a demonstration at Yale, and we were early on in supporting the development of health maintenance organizations. We were early funders of Harvard community health plan in Boston which was one of the first successful plans outside of the Kaiser pre-paid group pay practice model.
To visit the Commonwealth Fund's centennial website, click here.
Has the Commonwealth Fund done work internationally?
The Commonwealth Fund has also done a lot of international work and that’s becoming more interesting now to people in this particular time. We’re very proud of the fact that we have constantly demonstrated the alternatives and the availability of alternatives to the way we deliver care in the United States and we are continuing to do that. We believe that we have the best information available on alternative approaches to healthcare based on the other countries that we study intensively.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
